480 related articles for article (PubMed ID: 26699943)
1. Constitutive Reprogramming of Fibroblast Mitochondrial Metabolism in Pulmonary Hypertension.
Plecitá-Hlavatá L; Tauber J; Li M; Zhang H; Flockton AR; Pullamsetti SS; Chelladurai P; D'Alessandro A; El Kasmi KC; Ježek P; Stenmark KR
Am J Respir Cell Mol Biol; 2016 Jul; 55(1):47-57. PubMed ID: 26699943
[TBL] [Abstract][Full Text] [Related]
2. Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension Is Regulated Through a MicroRNA-124/PTBP1 (Polypyrimidine Tract Binding Protein 1)/Pyruvate Kinase Muscle Axis.
Zhang H; Wang D; Li M; Plecitá-Hlavatá L; D'Alessandro A; Tauber J; Riddle S; Kumar S; Flockton A; McKeon BA; Frid MG; Reisz JA; Caruso P; El Kasmi KC; Ježek P; Morrell NW; Hu CJ; Stenmark KR
Circulation; 2017 Dec; 136(25):2468-2485. PubMed ID: 28972001
[TBL] [Abstract][Full Text] [Related]
3. SIRT3 Is a Critical Regulator of Mitochondrial Function of Fibroblasts in Pulmonary Hypertension.
Li M; Plecitá-Hlavatá L; Dobrinskikh E; McKeon BA; Gandjeva A; Riddle S; Laux A; Prasad RR; Kumar S; Tuder RM; Zhang H; Hu CJ; Stenmark KR
Am J Respir Cell Mol Biol; 2023 Nov; 69(5):570-583. PubMed ID: 37343939
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Reprogramming Regulates the Proliferative and Inflammatory Phenotype of Adventitial Fibroblasts in Pulmonary Hypertension Through the Transcriptional Corepressor C-Terminal Binding Protein-1.
Li M; Riddle S; Zhang H; D'Alessandro A; Flockton A; Serkova NJ; Hansen KC; Moldovan R; McKeon BA; Frid M; Kumar S; Li H; Liu H; Caánovas A; Medrano JF; Thomas MG; Iloska D; Plecitá-Hlavatá L; Ježek P; Pullamsetti S; Fini MA; El Kasmi KC; Zhang Q; Stenmark KR
Circulation; 2016 Oct; 134(15):1105-1121. PubMed ID: 27562971
[TBL] [Abstract][Full Text] [Related]
5. Metabolic reprogramming and inflammation act in concert to control vascular remodeling in hypoxic pulmonary hypertension.
Stenmark KR; Tuder RM; El Kasmi KC
J Appl Physiol (1985); 2015 Nov; 119(10):1164-72. PubMed ID: 25930027
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin is an endogenous modulator of the constitutively activated phenotype of pulmonary adventitial fibroblasts in hypoxic pulmonary hypertension.
Anwar A; Li M; Frid MG; Kumar B; Gerasimovskaya EV; Riddle SR; McKeon BA; Thukaram R; Meyrick BO; Fini MA; Stenmark KR
Am J Physiol Lung Cell Mol Physiol; 2012 Jul; 303(1):L1-L11. PubMed ID: 22582113
[TBL] [Abstract][Full Text] [Related]
7. Metabolic Reprogramming and Redox Signaling in Pulmonary Hypertension.
Plecitá-Hlavatá L; D'alessandro A; El Kasmi K; Li M; Zhang H; Ježek P; Stenmark KR
Adv Exp Med Biol; 2017; 967():241-260. PubMed ID: 29047090
[TBL] [Abstract][Full Text] [Related]
8. Emergence of fibroblasts with a proinflammatory epigenetically altered phenotype in severe hypoxic pulmonary hypertension.
Li M; Riddle SR; Frid MG; El Kasmi KC; McKinsey TA; Sokol RJ; Strassheim D; Meyrick B; Yeager ME; Flockton AR; McKeon BA; Lemon DD; Horn TR; Anwar A; Barajas C; Stenmark KR
J Immunol; 2011 Sep; 187(5):2711-22. PubMed ID: 21813768
[TBL] [Abstract][Full Text] [Related]
9. Microenvironmental regulation of T-cells in pulmonary hypertension.
Plecitá-Hlavatá L; Brázdová A; Křivonosková M; Hu CJ; Phang T; Tauber J; Li M; Zhang H; Hoetzenecker K; Crnkovic S; Kwapiszewska G; Stenmark KR
Front Immunol; 2023; 14():1223122. PubMed ID: 37497214
[TBL] [Abstract][Full Text] [Related]
10. Microenvironmental Regulation of Macrophage Transcriptomic and Metabolomic Profiles in Pulmonary Hypertension.
Li M; Riddle S; Kumar S; Poczobutt J; McKeon BA; Frid MG; Ostaff M; Reisz JA; Nemkov T; Fini MA; Laux A; Hu CJ; El Kasmi KC; D'Alessandro A; Brown RD; Zhang H; Stenmark KR
Front Immunol; 2021; 12():640718. PubMed ID: 33868271
[TBL] [Abstract][Full Text] [Related]
11. Hallmarks of Pulmonary Hypertension: Mesenchymal and Inflammatory Cell Metabolic Reprogramming.
D'Alessandro A; El Kasmi KC; Plecitá-Hlavatá L; Ježek P; Li M; Zhang H; Gupte SA; Stenmark KR
Antioxid Redox Signal; 2018 Jan; 28(3):230-250. PubMed ID: 28637353
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitors synergize with sildenafil to suppress purine metabolism and proliferation in pulmonary hypertension.
Zhang H; D'Alessandro A; Li M; Reisz JA; Riddle S; Muralidhar A; Bull T; Zhao L; Gerasimovskaya E; Stenmark KR
Vascul Pharmacol; 2023 Apr; 149():107157. PubMed ID: 36849042
[TBL] [Abstract][Full Text] [Related]
13. Complement-containing small extracellular vesicles from adventitial fibroblasts induce proinflammatory and metabolic reprogramming in macrophages.
Kumar S; Frid MG; Zhang H; Li M; Riddle S; Brown RD; Yadav SC; Roy MK; Dzieciatkowska ME; D'Alessandro A; Hansen KC; Stenmark KR
JCI Insight; 2021 Nov; 6(21):. PubMed ID: 34499621
[TBL] [Abstract][Full Text] [Related]
14. Low-dose fluvastatin reverses the hypoxic pulmonary adventitial fibroblast phenotype in experimental pulmonary hypertension.
Carlin CM; Celnik DF; Pak O; Wadsworth R; Peacock AJ; Welsh DJ
Am J Respir Cell Mol Biol; 2012 Aug; 47(2):140-8. PubMed ID: 22383583
[TBL] [Abstract][Full Text] [Related]
15. Adventitial fibroblasts induce a distinct proinflammatory/profibrotic macrophage phenotype in pulmonary hypertension.
El Kasmi KC; Pugliese SC; Riddle SR; Poth JM; Anderson AL; Frid MG; Li M; Pullamsetti SS; Savai R; Nagel MA; Fini MA; Graham BB; Tuder RM; Friedman JE; Eltzschig HK; Sokol RJ; Stenmark KR
J Immunol; 2014 Jul; 193(2):597-609. PubMed ID: 24928992
[TBL] [Abstract][Full Text] [Related]
16. Metabolic consequences of NDUFS4 gene deletion in immortalized mouse embryonic fibroblasts.
Valsecchi F; Monge C; Forkink M; de Groof AJ; Benard G; Rossignol R; Swarts HG; van Emst-de Vries SE; Rodenburg RJ; Calvaruso MA; Nijtmans LG; Heeman B; Roestenberg P; Wieringa B; Smeitink JA; Koopman WJ; Willems PH
Biochim Biophys Acta; 2012 Oct; 1817(10):1925-36. PubMed ID: 22430089
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial hyperpolarization in pulmonary vascular remodeling. Mitochondrial uncoupling protein deficiency as disease model.
Pak O; Sommer N; Hoeres T; Bakr A; Waisbrod S; Sydykov A; Haag D; Esfandiary A; Kojonazarov B; Veit F; Fuchs B; Weisel FC; Hecker M; Schermuly RT; Grimminger F; Ghofrani HA; Seeger W; Weissmann N
Am J Respir Cell Mol Biol; 2013 Sep; 49(3):358-67. PubMed ID: 23590303
[TBL] [Abstract][Full Text] [Related]
18. Porcine Fetal-Derived Fibroblasts Alter Gene Expression and Mitochondria to Compensate for Hypoxic Stress During Culture.
Mordhorst BR; Murphy SL; Schauflinger M; Rojas Salazar S; Ji T; Behura SK; Wells KD; Green JA; Prather RS
Cell Reprogram; 2018 Aug; 20(4):225-235. PubMed ID: 30089028
[TBL] [Abstract][Full Text] [Related]
19. Uncoupling protein 2 deficiency mimics the effects of hypoxia and endoplasmic reticulum stress on mitochondria and triggers pseudohypoxic pulmonary vascular remodeling and pulmonary hypertension.
Dromparis P; Paulin R; Sutendra G; Qi AC; Bonnet S; Michelakis ED
Circ Res; 2013 Jul; 113(2):126-36. PubMed ID: 23652801
[TBL] [Abstract][Full Text] [Related]
20. BOLA (BolA Family Member 3) Deficiency Controls Endothelial Metabolism and Glycine Homeostasis in Pulmonary Hypertension.
Yu Q; Tai YY; Tang Y; Zhao J; Negi V; Culley MK; Pilli J; Sun W; Brugger K; Mayr J; Saggar R; Saggar R; Wallace WD; Ross DJ; Waxman AB; Wendell SG; Mullett SJ; Sembrat J; Rojas M; Khan OF; Dahlman JE; Sugahara M; Kagiyama N; Satoh T; Zhang M; Feng N; Gorcsan J; Vargas SO; Haley KJ; Kumar R; Graham BB; Langer R; Anderson DG; Wang B; Shiva S; Bertero T; Chan SY
Circulation; 2019 May; 139(19):2238-2255. PubMed ID: 30759996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
